Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512–22.

Article  PubMed  PubMed Central  Google Scholar 

Radtke A, Königsrainer A. Surgical Therapy of Cholangiocarcinoma. Visc Med. 2016;32:422–6.

Article  PubMed  PubMed Central  Google Scholar 

van Keulen A-M, Franssen S, van der Geest LG, de Boer MT, Coenraad M, van Driel LMJW, et al. Nationwide treatment and outcomes of perihilar cholangiocarcinoma. Liver Int. 2021;41:1945–53.

Article  PubMed  PubMed Central  Google Scholar 

Blechacz B, Cholangiocarcinoma. Current knowledge and New Developments. Gut Liver. 2017;11:13–26.

Article  PubMed  Google Scholar 

Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg. 2008;248:273–9.

Article  PubMed  Google Scholar 

Matsuo K, Rocha FG, Ito K, D’Angelica MI, Allen PJ, Fong Y, et al. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg. 2012;215:343–55.

Article  PubMed  Google Scholar 

Zhang H, Zhu J, Ke F, Weng M, Wu X, Li M, et al. Radiological imaging for assessing the respectability of Hilar Cholangiocarcinoma: a systematic review and Meta-analysis. Biomed Res Int. 2015;2015:497942.

PubMed  PubMed Central  Google Scholar 

Masselli G, Gualdi G. Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Abdom Imaging. 2008;33:444–51.

Article  PubMed  Google Scholar 

Kim DW, Kim SY, Yoo C, Hwang DW. Update on biliary Cancer imaging. Radiol Clin North Am. 2022;60:825–42.

Article  PubMed  Google Scholar 

Pang L, Bo X, Wang J, Wang C, Wang Y, Liu G, et al. Role of dual-time point 18F-FDG PET/CT imaging in the primary diagnosis and staging of hilar cholangiocarcinoma. Abdom Radiol. 2021;46:4138–47.

Article  Google Scholar 

Lamarca A, Barriuso J, Chander A, McNamara MG, Hubner RA, ÓReilly D, et al. 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: systematic review and meta-analysis. J Hepatol. 2019;71:115–29.

Article  PubMed  Google Scholar 

Fowler AM, Strigel RM. Clinical advances in PET-MRI for breast cancer. Lancet Oncol. 2022;23:e32–43.

Article  PubMed  PubMed Central  Google Scholar 

Mallak N, Hope TA, Guimaraes AR. PET/MR Imaging of the Pancreas. Magn Reson Imaging Clin N Am. 2018;26:345–62.

Article  PubMed  Google Scholar 

Obmann VC, Grosse-Hokamp N, Alberts I, Fulton N, Rassouli N, Siegel C, et al. Diagnosis and staging of hepatobiliary malignancies: potential incremental value of (18)F-FDG-PET/MRI compared to MRI of the liver. Nuklearmedizin. 2021;60:355–67.

Article  PubMed  Google Scholar 

Celebi F, Yaghouti K, Cindil E, Dogusoy GB, Tokat Y, Balci C. The role of 18F-FDG PET/MRI in the Assessment of primary intrahepatic neoplasms. Acad Radiol. 2021;28:189–98.

Article  PubMed  Google Scholar 

Yoo J, Lee JM, Yoon JH, Joo I, Lee DH. Additional value of Integrated (18)F-FDG PET/MRI for evaluating biliary Tract Cancer: comparison with contrast-enhanced CT. Korean J Radiol. 2021;22:714–24.

Article  PubMed  PubMed Central  Google Scholar 

Guniganti P, Kierans AS. PET/MRI of the hepatobiliary system: review of techniques and applications. Clin Imaging. 2021;71:160–9.

Article  PubMed  Google Scholar 

Boellaard R, Rausch I, Beyer T, Delso G, Yaqub M, Quick HH, et al. Quality control for quantitative multicenter whole-body PET/MR studies: a NEMA image quality phantom study with three current PET/MR systems. Med Phys. 2015;42:5961–9.

Article  PubMed  Google Scholar 

Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54.

Article  CAS  PubMed  Google Scholar 

Catalano OA, Rosen BR, Sahani DV, Hahn PF, Guimaraes AR, Vangel MG, et al. Clinical impact of PET/MR imaging in patients with Cancer undergoing same-day PET/CT: initial experience in 134 Patients—A hypothesis-generating exploratory study. Radiology. 2013;269:857–69.

Article  PubMed  Google Scholar 

Mayerhoefer ME, Prosch H, Beer L, Tamandl D, Beyer T, Hoeller C, et al. PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations. Eur J Nucl Med Mol Imaging. 2020;47:51–60.

Article  CAS  PubMed  Google Scholar 

Gleeson FC, Rajan E, Levy MJ, Clain JE, Topazian MD, Harewood GC, et al. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc. 2008;67:438–43.

Article  PubMed  Google Scholar 

Malikowski T, Levy MJ, Gleeson FC, Storm AC, Vargas EJ, Topazian MD, et al. Endoscopic Ultrasound/Fine needle aspiration is effective for Lymph Node staging in patients with Cholangiocarcinoma. Hepatology. 2020;72:940–8.

Article  CAS  PubMed  Google Scholar 

de Jong DM, van de Vondervoort S, Dwarkasing RS, Doukas M, Voermans RP, Verdonk RC, et al. Endoscopic ultrasound in patients with resectable perihilar cholangiocarcinoma: impact on clinical decision-making. Endosc Int Open. 2023;11:E162–8.

Article  PubMed  PubMed Central  Google Scholar 

de Jong DM, den Hoed CM, Willemssen F, Thomeer MGJ, Bruno MJ, Koerkamp BG, et al. Impact of EUS in liver transplantation workup for patients with unresectable perihilar cholangiocarcinoma. Gastrointest Endosc. 2024;99:548–56.

Article  PubMed  Google Scholar 

Martin O, Schaarschmidt BM, Kirchner J, Suntharalingam S, Grueneisen J, Demircioglu A, et al. PET/MRI Versus PET/CT for whole-body staging: results from a single-Center Observational Study on 1,003 sequential examinations. J Nucl Med. 2020;61:1131–6.

Article  CAS  PubMed  Google Scholar 

Spick C, Herrmann K, Czernin J. <sup > 18 F-FDG PET/CT and PET/MRI perform equally well in Cancer: evidence from studies on more than 2,300 Patients</sup >. J Nucl Med. 2016;57:420–30.

Article  CAS  PubMed  Google Scholar 

Hectors SJ, Wagner M, Besa C, Huang W, Taouli B. Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: initial experience. Volume 2018. Contrast Media & Molecular Imaging; 2018. p. 5638283.

Utsunomiya T, Ogawa K, Funamizu N, Sakamoto K, Watanabe J, Otani H, et al. The tumor-to-liver ratio of the standardized uptake value is a useful FDG-PET/CT parameter for predicting malignant intraductal papillary mucinous neoplasm of the pancreas. Ann Gastroenterol Surg. 2022;6:695–703.

Article  PubMed  PubMed Central  Google Scholar 

Kim TH, Ji YB, Song CM, Kim JY, Choi YY, Park JS, et al. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume. World J Surg Oncol. 2015;13:217.

Article  PubMed  PubMed Central  Google Scholar 

Tomimaru Y, Takeda Y, Tatsumi M, Kim T, Kobayashi S, Marubashi S, et al. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas. Oncol Rep. 2010;24:613–20.

PubMed  Google Scholar 

Chen H, Zhao L, Ruan D, Pang Y, Hao B, Dai Y, et al. Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings. Eur J Nucl Med Mol Imaging. 2021;48:73–86.

Article  PubMed  Google Scholar 

Dendl K, Koerber SA, Kratochwil C, Cardinale J, Finck R, Dabir M, et al. FAP and FAPI-PET/CT in malignant and non-malignant diseases: a perfect symbiosis? Cancers. 2021;13:4946.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Veldhuijzen SEM, Pieterman KJ, Wijnhoven BPL, Pruis IJ, Groot Koerkamp B, van Driel LMJW, et al. FAPI PET versus FDG PET, CT or MRI for staging Pancreatic-, gastric- and Cholangiocarcinoma: systematic review and head-to-head comparisons of Diagnostic performances. Diagnostics. 2022;12:1958.